Skip to content

APOTHEEK BODEN: what changed

What changed

APOTHEEK BODEN

BE 0834.059.250
NACE 47.730, Retail sale of pharmaceutical products
filed annual accounts (NBB)
Financial years compared with
Net result for the year
€77,387
2024 · €61,151+€16,236
Equity
€352,416
2024 · €285,029+€67,387
Cash
€230,943
2024 · €224,970+€5,974
Balance sheet total
€545,528
2024 · €515,640+€29,888

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€32,038

    up €32,038 (+52.3%), from €61,222 to €93,261

    of which Trade receivables: +€33,711

  • Tangible fixed assets -€22,849

    down €22,849 (-18.2%), from €125,759 to €102,909

  • Stocks and contracts +€15,226

    up €15,226 (+15.9%), from €95,849 to €111,075

  • Cash +€5,974

    up €5,974 (+2.7%), from €224,970 to €230,943

    mainly Net result for the year (+€77,387) and Depreciation (+€24,849)

Equity and liabilities
  • Reserves +€67,387

    up €67,387 (+25.4%), from €265,000 to €332,387

  • Other debts -€34,424

    down €34,424 (-43.6%), from €79,007 to €44,583

  • Trade debts +€21,455

    up €21,455 (+67.7%), from €31,681 to €53,136

  • Debts after one year -€18,620

    down €18,620 (-26.8%), from €69,379 to €50,759

Income statement
  • Gross operating margin +€21,373

    up €21,373 (+11.4%), from €187,634 to €209,007

  • Staff costs +€2,615

    up €2,615 (+3.8%), from €68,069 to €70,684

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €61,151
Gross operating margin +€21,373
Staff costs -€2,615
Depreciation -€1,663
Other operating charges -€41
Financial income -€103
Financial charges +€15
Taxes -€730
Result 2025 €77,387
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€36,371
Investment -€1,999
Financing -€28,398
Cash 2024 €224,970
Net result for the year +€77,387
Depreciation +€24,849
Stocks and contracts -€15,226
Receivables within one year -€32,038
Deferred charges and accrued income +€501
Trade debts +€21,455
Tax, wage and social debts -€4,839
Other debts -€34,424
Accrued charges and deferred income -€1,294
Investment in fixed assets (net) -€1,999
Debts after one year -€18,620
Current portion of long-term debt +€222
Contributions, distributions and other -€10,000
Cash 2025 €230,943
brings cash intakes cash out
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €515,640 €545,528 +€29,888 +5.8%
Fixed assets 21/28 €125,759 €102,909 -€22,849 -18.2%
Tangible fixed assets 22/27 €125,759 €102,909 -€22,849 -18.2%
Plant, machinery and equipment 23 €125,759 €102,909 -€22,849 -18.2%
Current assets 29/58 €389,881 €442,619 +€52,737 +13.5%
Stocks and contracts in progress 3 €95,849 €111,075 +€15,226 +15.9%
Stocks 30/36 €95,849 €111,075 +€15,226 +15.9%
Amounts receivable within one year 40/41 €61,222 €93,261 +€32,038 +52.3%
Trade receivables 40 €59,549 €93,261 +€33,711 +56.6%
Other amounts receivable 41 €1,673 €0 -€1,673 -100%
Cash at bank and in hand 54/58 €224,970 €230,943 +€5,974 +2.7%
Deferred charges and accrued income 490/1 €7,840 €7,339 -€501 -6.4%
Total equity and liabilities 10/49 €515,640 €545,528 +€29,888 +5.8%
Equity 10/15 €285,029 €352,416 +€67,387 +23.6%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €265,000 €332,387 +€67,387 +25.4%
Distributable reserves 133 €265,000 €332,387 +€67,387 +25.4%
Profit (loss) carried forward 14 €1,429 €1,429 = 0.0%
Amounts payable 17/49 €230,611 €193,112 -€37,500 -16.3%
Amounts payable after more than one year 17 €69,379 €50,759 -€18,620 -26.8%
Financial debts 170/4 €69,379 €50,759 -€18,620 -26.8%
Amounts payable within one year 42/48 €156,497 €138,911 -€17,586 -11.2%
Current portion of amounts payable after more than one year 42 €18,398 €18,620 +€222 +1.2%
Trade debts 44 €31,681 €53,136 +€21,455 +67.7%
Suppliers 440/4 €31,681 €53,136 +€21,455 +67.7%
Taxes, remuneration and social security 45 €27,411 €22,572 -€4,839 -17.7%
Taxes 450/3 €19,471 €14,260 -€5,211 -26.8%
Remuneration and social security 454/9 €7,940 €8,312 +€372 +4.7%
Other amounts payable 47/48 €79,007 €44,583 -€34,424 -43.6%
Accrued charges and deferred income 492/3 €4,735 €3,441 -€1,294 -27.3%
Remuneration, social security and pensions 62 €68,069 €70,684 +€2,615 +3.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €23,185 €24,849 +€1,663 +7.2%
Other operating charges 640/8 €1,023 €1,064 +€41 +4.0%
Gross operating margin 9900 €187,634 €209,007 +€21,373 +11.4%
Operating profit (loss) 9901 €95,357 €112,410 +€17,053 +17.9%
Financial income 75/76B €2,551 €2,448 -€103 -4.0%
Recurring financial income 75 €2,551 €2,448 -€103 -4.0%
Financial charges 65/66B €6,272 €6,257 -€15 -0.2%
Recurring financial charges 65 €6,272 €6,257 -€15 -0.2%
Profit (loss) for the period before taxes 9903 €91,636 €108,601 +€16,966 +18.5%
Income taxes 67/77 €30,484 €31,214 +€730 +2.4%
Profit (loss) for the period 9904 €61,151 €77,387 +€16,236 +26.6%
Profit (loss) for the period to be appropriated 9905 €61,151 €77,387 +€16,236 +26.6%
Calculation and sources

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.